173 related articles for article (PubMed ID: 35329862)
21. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
22. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders.
Rees JH; Hain SF; Johnson MR; Hughes RA; Costa DC; Ell PJ; Keir G; Rudge P
Brain; 2001 Nov; 124(Pt 11):2223-31. PubMed ID: 11673324
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients.
Lehman VT; Barrick BJ; Pittelkow MR; Peller PJ; Camilleri MJ; Lehman JS
Int J Dermatol; 2015 Apr; 54(4):424-37. PubMed ID: 25069905
[TBL] [Abstract][Full Text] [Related]
24. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic neurologic syndromes in children: a review article.
Alavi S
Iran J Child Neurol; 2013; 7(3):6-14. PubMed ID: 24665300
[TBL] [Abstract][Full Text] [Related]
26. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
28.
Bresler R; Schroeder HW; Chow DZ; Lim R
World J Nucl Med; 2020; 19(2):124-130. PubMed ID: 32939199
[TBL] [Abstract][Full Text] [Related]
29. Initial experience in assessing diagnostic utility of conventional and functional imaging (staging CT, PET CT, and MRI Brain/Spine) in suspected cases of paraneoplastic neurological syndrome.
Sanyal SR; Kodituwakku K; Nisreen A; Kilani SM; Gupta M
J Neurosci Rural Pract; 2023; 14(1):170-176. PubMed ID: 36891093
[TBL] [Abstract][Full Text] [Related]
30. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
Zaborowski MP; Stefens-Stawna P; Osztynowicz K; Piorunek T; Batura-Gabryel H; Dyzmann-Sroka A; Kozubski W; Nowak-Markwitz E; Michalak S
Cancer Immunol Immunother; 2021 May; 70(5):1277-1289. PubMed ID: 33136178
[TBL] [Abstract][Full Text] [Related]
31. Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
Patel RR; Subramaniam RM; Mandrekar JN; Hammack JE; Lowe VJ; Jett JR
Mayo Clin Proc; 2008 Aug; 83(8):917-22. PubMed ID: 18674476
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
Thapa P; Basu S
J Nucl Med Technol; 2016 Mar; 44(1):52-3. PubMed ID: 26271804
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
34. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
36. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.
Linke R; Schroeder M; Helmberger T; Voltz R
Neurology; 2004 Jul; 63(2):282-6. PubMed ID: 15277621
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Chatterjee M; Hurley LC; Tainsky MA
Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune response in lung cancer patients with neurological paraneoplastic syndromes.
Michalak S; Piorunek T; Zaborowski M; Rybacka-Mossakowska J; Stefens-Stawna P; Kalinowska-Łyszczarz A; Kozubski W; Batura-Gabryel H
Neurol Neurochir Pol; 2019; 53(3):217-226. PubMed ID: 31187476
[TBL] [Abstract][Full Text] [Related]
39. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
